It's official: needle-free epinephrine is coming to Canada. In April 2026, Health Canada approved Neffy® — the first epinephrine nasal spray — and it's expected to reach Canadian pharmacies this summer. For allergy families who've spent years carrying auto-injectors, this is news worth paying attention to.
What is Neffy?
Neffy is emergency epinephrine you spray into the nose instead of injecting — no needle. It's tiny, about the size of a key fob, and comes as a two-spray pack you're meant to carry together, the same way you'd carry a backup auto-injector today.
What it means for Canadian families
Right now, Neffy is approved in Canada for kids and adults who weigh about 30 kg (66 lb) and up, with a lower dose for younger children expected to follow. As with any change to how you manage anaphylaxis, whether Neffy is right for your family is a conversation for you and your allergist — we make the carriers, not the medicine.
Why we're paying attention
- It's needle-free. For a needle-shy kid — or a nervous parent — that can make a real difference in the willingness to act fast.
- It's small and simple. Two little sprays slip into a pocket, a backpack, or a pouch with room to spare.
- It's more forgiving with temperature. Neffy has been shown to hold up better than traditional auto-injectors when temperatures climb — exactly the kind of peace of mind so many of you have told us you want on hot summer days.
The pouch we're making for it
We've already ordered Neffy samples, and we are designing an Epicute pouch sized perfectly for the two-spray pack — the same fun, safety-first, parent-to-parent carriers you know, reimagined for a new kind of epinephrine. We're building it now so it's ready for your family whenever you make the switch.
Be first in line
Want to know the moment it's ready? Join our Neffy pouch waitlist and you'll get the first email — and first access — when we launch. 💛
This article is for information only and isn't medical advice. Always follow the guidance of your doctor or allergist, and keep carrying your current EpiPen® or Allerject® until you and your healthcare provider decide together to make a change.